Zipject
Its all about confidence in mgmt. they said Copaxone is fully characterized, so i expect that they will receive the same treatment as Lovenox - i.e. approval from the FDA, its a matter of time
i cant comprehend/accept comments like - fda approval is more of a risk by an order of magnitude..., its bs pretty much. they have the technology, people and we know lovenox is much harder to copy than copaxone, so i dont see a problem with FDA.
Market Data 
Markets 
AI
